RAJAF (Cordyceps Sunshine Biotech Holdings Co) LT-Debt-to-Total-Asset : 0.17 (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Cordyceps Sunshine Biotech Holdings Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Cordyceps Sunshine Biotech Holdings Co's long-term debt to total assests ratio for the quarter that ended in Dec. 2023 was 0.17.

Cordyceps Sunshine Biotech Holdings Co's long-term debt to total assets ratio declined from Dec. 2021 (0.19) to Dec. 2023 (0.17). It may suggest that Cordyceps Sunshine Biotech Holdings Co is progressively becoming less dependent on debt to grow their business.

Cordyceps Sunshine Biotech Holdings Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Cordyceps Sunshine Biotech Holdings Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cordyceps Sunshine Biotech Holdings Co LT-Debt-to-Total-Asset Chart

Cordyceps Sunshine Biotech Holdings Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

0.15

0.19

0.25

0.17

Cordyceps Sunshine Biotech Holdings Co Quarterly Data
	Dec20	Dec21	Sep22	Dec22	Sep23	Dec23
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial			0.19	-	0.25	0.29	0.17

Cordyceps Sunshine Biotech Holdings Co LT-Debt-to-Total-Asset Calculation

Cordyceps Sunshine Biotech Holdings Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	0.572	/	3.422
	=	0.17

Cordyceps Sunshine Biotech Holdings Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (Q: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2023 )	/	Total Assets (Q: Dec. 2023 )
	=	0.572	/	3.422
	=	0.17

Cordyceps Sunshine Biotech Holdings Co (OTCPK:RAJAF) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Cordyceps Sunshine Biotech Holdings Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Cordyceps Sunshine Biotech Holdings Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Cordyceps Sunshine Biotech Holdings Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Cordyceps Sunshine Biotech Holdings Co Ltd (OTCPK:RAJAF) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lane 548, Ruiguang Road, 6th Floor, No. 15, Neihu District, Taipei City, TWN

Website

http://www.cordyceps-sunshine.com

Cordyceps Sunshine Biotech Holdings Co Ltd engages in cultivating Chinese rare medicinal herbs, Cattle camphor mushroom raw materials, and selling its finished products. The company has one business segment: cultivating and sales of Chinese rare medicinal herb, taiwanofungus raw material, and its finished products. The company generates revenue from product sales, training, and related parties.

Cordyceps Sunshine Biotech Holdings Co Headlines

No Headlines